

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.38146740 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.38146740 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.05635903 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.05635903 |
| 5 | sulfur amino acid catabolic process (GO:0000098) | 5.08074825 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 5.03635349 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 4.92596673 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 4.92596673 |
| 9 | cysteine metabolic process (GO:0006534) | 4.65561975 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.43261333 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.39150840 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.19632327 |
| 13 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16604526 |
| 14 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.13725529 |
| 15 | protein carboxylation (GO:0018214) | 4.13725529 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.13299864 |
| 17 | valine metabolic process (GO:0006573) | 4.09301557 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.05693546 |
| 19 | protein maturation by protein folding (GO:0022417) | 4.01551531 |
| 20 | cellular modified amino acid catabolic process (GO:0042219) | 3.97572406 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 3.94282539 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 3.94282539 |
| 23 | tryptophan catabolic process (GO:0006569) | 3.94282539 |
| 24 | coenzyme catabolic process (GO:0009109) | 3.91541952 |
| 25 | complement activation, alternative pathway (GO:0006957) | 3.90346670 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 3.88956246 |
| 27 | tryptophan metabolic process (GO:0006568) | 3.86146797 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.85244450 |
| 29 | lysine catabolic process (GO:0006554) | 3.84609114 |
| 30 | lysine metabolic process (GO:0006553) | 3.84609114 |
| 31 | urea metabolic process (GO:0019627) | 3.83901725 |
| 32 | urea cycle (GO:0000050) | 3.83901725 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 3.81442771 |
| 34 | reverse cholesterol transport (GO:0043691) | 3.80609522 |
| 35 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.80349294 |
| 36 | regulation of protein activation cascade (GO:2000257) | 3.77069312 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 3.73530398 |
| 38 | macromolecular complex remodeling (GO:0034367) | 3.73530398 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 3.73530398 |
| 40 | aromatic amino acid family metabolic process (GO:0009072) | 3.73125849 |
| 41 | intestinal cholesterol absorption (GO:0030299) | 3.72983839 |
| 42 | bile acid metabolic process (GO:0008206) | 3.71189382 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 3.67684406 |
| 44 | barbed-end actin filament capping (GO:0051016) | 3.64275164 |
| 45 | COPII vesicle coating (GO:0048208) | 3.63313406 |
| 46 | regulation of fibrinolysis (GO:0051917) | 3.60667760 |
| 47 | tyrosine metabolic process (GO:0006570) | 3.59737965 |
| 48 | glycosphingolipid catabolic process (GO:0046479) | 3.59327415 |
| 49 | regulation of complement activation (GO:0030449) | 3.59122070 |
| 50 | nitrogen cycle metabolic process (GO:0071941) | 3.59086711 |
| 51 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.57797274 |
| 52 | low-density lipoprotein particle remodeling (GO:0034374) | 3.56000911 |
| 53 | signal peptide processing (GO:0006465) | 3.54910367 |
| 54 | regulation of triglyceride catabolic process (GO:0010896) | 3.54770398 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 3.54767001 |
| 56 | homocysteine metabolic process (GO:0050667) | 3.54393164 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.53407261 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 3.51855851 |
| 59 | ethanol oxidation (GO:0006069) | 3.47427202 |
| 60 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.44044655 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 3.42723222 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 3.41377675 |
| 63 | aldehyde catabolic process (GO:0046185) | 3.41140086 |
| 64 | keratan sulfate catabolic process (GO:0042340) | 3.40936238 |
| 65 | aspartate family amino acid catabolic process (GO:0009068) | 3.39314494 |
| 66 | branched-chain amino acid metabolic process (GO:0009081) | 3.39025237 |
| 67 | cofactor catabolic process (GO:0051187) | 3.38274532 |
| 68 | amino-acid betaine metabolic process (GO:0006577) | 3.38229383 |
| 69 | glycolipid catabolic process (GO:0019377) | 3.36297058 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 3.35526976 |
| 71 | serine family amino acid catabolic process (GO:0009071) | 3.34932293 |
| 72 | 4-hydroxyproline metabolic process (GO:0019471) | 3.34921978 |
| 73 | triglyceride homeostasis (GO:0070328) | 3.33072570 |
| 74 | acylglycerol homeostasis (GO:0055090) | 3.33072570 |
| 75 | regulation of cholesterol metabolic process (GO:0090181) | 3.33028041 |
| 76 | bile acid and bile salt transport (GO:0015721) | 3.33017877 |
| 77 | drug transmembrane transport (GO:0006855) | 3.31493383 |
| 78 | cellular glucuronidation (GO:0052695) | 3.30393198 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 3.30219890 |
| 80 | GDP-mannose metabolic process (GO:0019673) | 3.28901023 |
| 81 | organic acid catabolic process (GO:0016054) | 3.25290736 |
| 82 | carboxylic acid catabolic process (GO:0046395) | 3.25290736 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.24240707 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 3.23173670 |
| 85 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.22255336 |
| 86 | protein retention in ER lumen (GO:0006621) | 3.21727950 |
| 87 | serine family amino acid metabolic process (GO:0009069) | 3.20624127 |
| 88 | glucuronate metabolic process (GO:0019585) | 3.19987706 |
| 89 | uronic acid metabolic process (GO:0006063) | 3.19987706 |
| 90 | fatty acid catabolic process (GO:0009062) | 3.19915867 |
| 91 | fatty acid oxidation (GO:0019395) | 3.17094337 |
| 92 | monocarboxylic acid catabolic process (GO:0072329) | 3.16310797 |
| 93 | lipid oxidation (GO:0034440) | 3.12433502 |
| 94 | hormone catabolic process (GO:0042447) | 3.11440178 |
| 95 | negative regulation of cholesterol transport (GO:0032375) | 3.10967715 |
| 96 | negative regulation of sterol transport (GO:0032372) | 3.10967715 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 3.09445470 |
| 98 | benzene-containing compound metabolic process (GO:0042537) | 3.07498435 |
| 99 | amino sugar catabolic process (GO:0046348) | 3.07468092 |
| 100 | phospholipid efflux (GO:0033700) | 3.07461649 |
| 101 | complement activation, classical pathway (GO:0006958) | 3.06994351 |
| 102 | pinocytosis (GO:0006907) | 3.06517492 |
| 103 | response to nitrosative stress (GO:0051409) | 3.06407315 |
| 104 | cholesterol efflux (GO:0033344) | 3.04136759 |
| 105 | glutamate metabolic process (GO:0006536) | 3.01325042 |
| 106 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.01277113 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.01277113 |
| 108 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.01142921 |
| 109 | adhesion of symbiont to host (GO:0044406) | 3.00466739 |
| 110 | regulation of cholesterol homeostasis (GO:2000188) | 2.99761072 |
| 111 | acetyl-CoA metabolic process (GO:0006084) | 2.96234374 |
| 112 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.96094843 |
| 113 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96028280 |
| 114 | virion attachment to host cell (GO:0019062) | 2.94658609 |
| 115 | adhesion of symbiont to host cell (GO:0044650) | 2.94658609 |
| 116 | ceramide catabolic process (GO:0046514) | 2.94161176 |
| 117 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.93558705 |
| 118 | response to thyroid hormone (GO:0097066) | 2.93256051 |
| 119 | hyaluronan catabolic process (GO:0030214) | 2.85706236 |
| 120 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.85317064 |
| 121 | xenobiotic catabolic process (GO:0042178) | 2.82775160 |
| 122 | sphingolipid catabolic process (GO:0030149) | 2.79507749 |
| 123 | protein localization to endosome (GO:0036010) | 2.79345957 |
| 124 | amyloid precursor protein catabolic process (GO:0042987) | 2.78666475 |
| 125 | membrane lipid catabolic process (GO:0046466) | 2.78666006 |
| 126 | type B pancreatic cell proliferation (GO:0044342) | 2.77199946 |
| 127 | skin morphogenesis (GO:0043589) | 2.70031556 |
| 128 | low-density lipoprotein particle clearance (GO:0034383) | 2.66024217 |
| 129 | mannose metabolic process (GO:0006013) | 2.64215512 |
| 130 | polyketide metabolic process (GO:0030638) | 2.61679692 |
| 131 | doxorubicin metabolic process (GO:0044598) | 2.61679692 |
| 132 | daunorubicin metabolic process (GO:0044597) | 2.61679692 |
| 133 | regulation of metalloenzyme activity (GO:0048552) | 2.61464531 |
| 134 | glucose catabolic process (GO:0006007) | 2.59430660 |
| 135 | extracellular fibril organization (GO:0043206) | 2.58812382 |
| 136 | pentose-phosphate shunt (GO:0006098) | 2.53709960 |
| 137 | regulation of cholesterol storage (GO:0010885) | 2.52475718 |
| 138 | fibril organization (GO:0097435) | 2.52043292 |
| 139 | apoptotic cell clearance (GO:0043277) | 2.49981256 |
| 140 | fibrinolysis (GO:0042730) | 2.46869443 |
| 141 | galactose catabolic process (GO:0019388) | 2.44900070 |
| 142 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.44461998 |
| 143 | glycoside metabolic process (GO:0016137) | 2.42487180 |
| 144 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.41665014 |
| 145 | cell adhesion mediated by integrin (GO:0033627) | 2.40972702 |
| 146 | cellular copper ion homeostasis (GO:0006878) | 2.35382686 |
| 147 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.35326844 |
| 148 | UV protection (GO:0009650) | 2.32339683 |
| 149 | glucosamine-containing compound catabolic process (GO:1901072) | 2.30921232 |
| 150 | regulation of extracellular matrix disassembly (GO:0010715) | 2.30346974 |
| 151 | endosome to pigment granule transport (GO:0043485) | 2.28939261 |
| 152 | endosome to melanosome transport (GO:0035646) | 2.28939261 |
| 153 | cellular response to zinc ion (GO:0071294) | 2.28041687 |
| 154 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.27522692 |
| 155 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.23647032 |
| 156 | cellular response to arsenic-containing substance (GO:0071243) | 2.23595636 |
| 157 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.21684610 |
| 158 | cellular response to cadmium ion (GO:0071276) | 2.20487468 |
| 159 | regulation of plasminogen activation (GO:0010755) | 2.20165629 |
| 160 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.19891515 |
| 161 | L-ascorbic acid metabolic process (GO:0019852) | 2.17589394 |
| 162 | acute-phase response (GO:0006953) | 2.17490743 |
| 163 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.16536747 |
| 164 | negative regulation of protein activation cascade (GO:2000258) | 2.16498959 |
| 165 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.15866551 |
| 166 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.13208855 |
| 167 | NADPH regeneration (GO:0006740) | 2.13089626 |
| 168 | NADH metabolic process (GO:0006734) | 2.13015205 |
| 169 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.12457984 |
| 170 | negative regulation of complement activation (GO:0045916) | 2.12217286 |
| 171 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.10653593 |
| 172 | regulation of superoxide anion generation (GO:0032928) | 2.10187945 |
| 173 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.09065601 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.08510693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.11114921 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33829487 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.55344986 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97185559 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.77506017 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.47155791 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.39476070 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.33689273 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.59004625 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.36441249 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.72591599 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.44862200 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.34796165 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.29084999 |
| 15 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.23452763 |
| 16 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.01673113 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.92946172 |
| 18 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.90424913 |
| 19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.85010722 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.79929196 |
| 21 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.75214901 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73531649 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.71734763 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67410969 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.65747588 |
| 26 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.64329982 |
| 27 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.63768367 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56118583 |
| 29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.54364581 |
| 30 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.46586437 |
| 31 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44385844 |
| 32 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40097383 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37898867 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.36302574 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35556592 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32004602 |
| 37 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29935060 |
| 38 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29761961 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29145337 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28057886 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25079682 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.23799104 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.22180783 |
| 44 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21357911 |
| 45 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21096754 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20737183 |
| 47 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.19469773 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18325064 |
| 49 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17800454 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16710007 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14726411 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13883664 |
| 53 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13390623 |
| 54 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.12051194 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11224331 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11037676 |
| 57 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09253534 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.09106483 |
| 59 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.08963794 |
| 60 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08190856 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08164116 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08149932 |
| 63 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.08070643 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07841034 |
| 65 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.07192974 |
| 66 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.06867451 |
| 67 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.06207373 |
| 68 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04789865 |
| 69 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04789865 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04627590 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04466606 |
| 72 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04424847 |
| 73 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04331772 |
| 74 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03596597 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03168120 |
| 76 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03098567 |
| 77 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02650196 |
| 78 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01904272 |
| 79 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.01613114 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01078424 |
| 81 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00871217 |
| 82 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00365571 |
| 83 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99264046 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98884962 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98842612 |
| 86 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98536433 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98413031 |
| 88 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98357880 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98250546 |
| 90 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97949914 |
| 91 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.97402337 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96224116 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95878195 |
| 94 | P68_20966046_ChIP-Seq_HELA_Human | 0.95451729 |
| 95 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95187911 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95174794 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93891947 |
| 98 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91699118 |
| 99 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91368686 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91175691 |
| 101 | AR_20517297_ChIP-Seq_VCAP_Human | 0.90482419 |
| 102 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90451084 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86228089 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84483951 |
| 105 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83763133 |
| 106 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83319072 |
| 107 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82447711 |
| 108 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81886342 |
| 109 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.80420164 |
| 110 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78022024 |
| 111 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.76697255 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76057307 |
| 113 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75144410 |
| 114 | * RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74882406 |
| 115 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.74831067 |
| 116 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.74652603 |
| 117 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.74305893 |
| 118 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.73426804 |
| 119 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.73375569 |
| 120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72808494 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.72550764 |
| 122 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71930284 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.71300967 |
| 124 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70712872 |
| 125 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.70210573 |
| 126 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.68820929 |
| 127 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.68494726 |
| 128 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.68293012 |
| 129 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.67852941 |
| 130 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.67744745 |
| 131 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67724800 |
| 132 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.67365341 |
| 133 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.67255195 |
| 134 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66802762 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66320543 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.66214226 |
| 137 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.65312834 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64968882 |
| 139 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.64438660 |
| 140 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.64109297 |
| 141 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.63816527 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.63623698 |
| 143 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.63623698 |
| 144 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.63212484 |
| 145 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.63044354 |
| 146 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.62955870 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61216366 |
| 148 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.59284502 |
| 149 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.58547357 |
| 150 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58421554 |
| 151 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.57598432 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.54392403 |
| 2 | MP0005365_abnormal_bile_salt | 5.45706097 |
| 3 | MP0005360_urolithiasis | 5.22988418 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.76147528 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.96619255 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.78946918 |
| 7 | MP0005083_abnormal_biliary_tract | 3.38687621 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.11846221 |
| 9 | MP0003195_calcinosis | 2.89423734 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.88710453 |
| 11 | MP0009840_abnormal_foam_cell | 2.88531932 |
| 12 | MP0003252_abnormal_bile_duct | 2.85915697 |
| 13 | MP0005332_abnormal_amino_acid | 2.66100746 |
| 14 | MP0003868_abnormal_feces_composition | 2.47068433 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.22351370 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.08849643 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.08000802 |
| 18 | MP0005220_abnormal_exocrine_pancreas | 1.98222803 |
| 19 | MP0001764_abnormal_homeostasis | 1.91070798 |
| 20 | MP0009643_abnormal_urine_homeostasis | 1.87699137 |
| 21 | MP0003279_aneurysm | 1.84878288 |
| 22 | MP0004272_abnormal_basement_membrane | 1.82507468 |
| 23 | MP0000609_abnormal_liver_physiology | 1.81483784 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.80384747 |
| 25 | MP0003075_altered_response_to | 1.78994355 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.75454367 |
| 27 | MP0005257_abnormal_intraocular_pressure | 1.73229424 |
| 28 | MP0003186_abnormal_redox_activity | 1.68936720 |
| 29 | MP0005165_increased_susceptibility_to | 1.68686651 |
| 30 | MP0004043_abnormal_pH_regulation | 1.67639545 |
| 31 | MP0000343_altered_response_to | 1.66640561 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.66595296 |
| 33 | MP0005275_abnormal_skin_tensile | 1.63306386 |
| 34 | MP0005023_abnormal_wound_healing | 1.53736310 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.53184849 |
| 36 | MP0005410_abnormal_fertilization | 1.53057871 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.50050029 |
| 38 | MP0001542_abnormal_bone_strength | 1.48340490 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 1.46451428 |
| 40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.39937809 |
| 41 | MP0005670_abnormal_white_adipose | 1.37713783 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.36711580 |
| 43 | MP0003566_abnormal_cell_adhesion | 1.36561534 |
| 44 | MP0002138_abnormal_hepatobiliary_system | 1.36448249 |
| 45 | MP0001958_emphysema | 1.35885826 |
| 46 | MP0003436_decreased_susceptibility_to | 1.35375489 |
| 47 | MP0003656_abnormal_erythrocyte_physiolo | 1.30666864 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.26605591 |
| 49 | MP0000858_altered_metastatic_potential | 1.22079134 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.20661490 |
| 51 | MP0005647_abnormal_sex_gland | 1.20377090 |
| 52 | MP0008260_abnormal_autophagy | 1.18959959 |
| 53 | MP0004510_myositis | 1.18296662 |
| 54 | MP0002419_abnormal_innate_immunity | 1.17583942 |
| 55 | MP0001944_abnormal_pancreas_morphology | 1.17508055 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.16629250 |
| 57 | MP0002254_reproductive_system_inflammat | 1.15606043 |
| 58 | MP0001853_heart_inflammation | 1.15462538 |
| 59 | MP0009785_altered_susceptibility_to | 1.15208748 |
| 60 | MP0002078_abnormal_glucose_homeostasis | 1.15044215 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.14802892 |
| 62 | MP0003300_gastrointestinal_ulcer | 1.12453091 |
| 63 | MP0001765_abnormal_ion_homeostasis | 1.11113331 |
| 64 | MP0005164_abnormal_response_to | 1.10833007 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.09766125 |
| 66 | MP0000598_abnormal_liver_morphology | 1.08676467 |
| 67 | MP0001756_abnormal_urination | 1.07737834 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 1.07404322 |
| 69 | MP0000013_abnormal_adipose_tissue | 1.07340137 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.07144892 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.04215964 |
| 72 | MP0001243_abnormal_dermal_layer | 1.03463720 |
| 73 | MP0003303_peritoneal_inflammation | 1.02534864 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.01565546 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 1.01201743 |
| 76 | MP0006036_abnormal_mitochondrial_physio | 1.01015717 |
| 77 | MP0005666_abnormal_adipose_tissue | 1.00873262 |
| 78 | MP0000681_abnormal_thyroid_gland | 1.00160433 |
| 79 | MP0000604_amyloidosis | 0.99217723 |
| 80 | MP0005084_abnormal_gallbladder_morpholo | 0.97188399 |
| 81 | MP0005408_hypopigmentation | 0.96618763 |
| 82 | MP0005451_abnormal_body_composition | 0.95442952 |
| 83 | MP0009642_abnormal_blood_homeostasis | 0.94796478 |
| 84 | MP0003011_delayed_dark_adaptation | 0.94277693 |
| 85 | MP0001881_abnormal_mammary_gland | 0.94271937 |
| 86 | MP0008469_abnormal_protein_level | 0.93248529 |
| 87 | MP0002877_abnormal_melanocyte_morpholog | 0.93043228 |
| 88 | MP0001545_abnormal_hematopoietic_system | 0.91324153 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.91324153 |
| 90 | MP0002295_abnormal_pulmonary_circulatio | 0.89811142 |
| 91 | MP0008004_abnormal_stomach_pH | 0.89694748 |
| 92 | MP0005025_abnormal_response_to | 0.88355695 |
| 93 | MP0005166_decreased_susceptibility_to | 0.87988146 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.87701578 |
| 95 | MP0006054_spinal_hemorrhage | 0.86917516 |
| 96 | MP0005535_abnormal_body_temperature | 0.85965783 |
| 97 | MP0003091_abnormal_cell_migration | 0.85938584 |
| 98 | MP0000685_abnormal_immune_system | 0.84929137 |
| 99 | MP0009763_increased_sensitivity_to | 0.84325084 |
| 100 | MP0005390_skeleton_phenotype | 0.84092209 |
| 101 | MP0006082_CNS_inflammation | 0.83684085 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.83277291 |
| 103 | MP0003724_increased_susceptibility_to | 0.80950662 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.80635236 |
| 105 | MP0005330_cardiomyopathy | 0.80546460 |
| 106 | MP0003795_abnormal_bone_structure | 0.80264629 |
| 107 | MP0005503_abnormal_tendon_morphology | 0.79605438 |
| 108 | MP0009764_decreased_sensitivity_to | 0.78897412 |
| 109 | MP0005334_abnormal_fat_pad | 0.78625258 |
| 110 | MP0000538_abnormal_urinary_bladder | 0.78337732 |
| 111 | MP0001216_abnormal_epidermal_layer | 0.78302639 |
| 112 | MP0003329_amyloid_beta_deposits | 0.77812395 |
| 113 | MP0001661_extended_life_span | 0.76474460 |
| 114 | MP0001849_ear_inflammation | 0.75744381 |
| 115 | MP0004858_abnormal_nervous_system | 0.75036083 |
| 116 | MP0005376_homeostasis/metabolism_phenot | 0.74582922 |
| 117 | MP0000613_abnormal_salivary_gland | 0.74468348 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.74289708 |
| 119 | MP0004947_skin_inflammation | 0.74250813 |
| 120 | MP0002796_impaired_skin_barrier | 0.74054754 |
| 121 | MP0003953_abnormal_hormone_level | 0.73339010 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.73216935 |
| 123 | MP0005448_abnormal_energy_balance | 0.72533019 |
| 124 | MP0003705_abnormal_hypodermis_morpholog | 0.72299351 |
| 125 | MP0002136_abnormal_kidney_physiology | 0.72029471 |
| 126 | MP0003959_abnormal_lean_body | 0.72022226 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.71904649 |
| 128 | MP0004130_abnormal_muscle_cell | 0.69796726 |
| 129 | MP0009697_abnormal_copulation | 0.68312454 |
| 130 | MP0001664_abnormal_digestion | 0.67286882 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.66036807 |
| 132 | MP0000230_abnormal_systemic_arterial | 0.66006547 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.65977493 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.65429619 |
| 135 | MP0004782_abnormal_surfactant_physiolog | 0.64509101 |
| 136 | MP0003690_abnormal_glial_cell | 0.63993867 |
| 137 | MP0002971_abnormal_brown_adipose | 0.62187401 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.61483193 |
| 139 | MP0003283_abnormal_digestive_organ | 0.59185630 |
| 140 | MP0010368_abnormal_lymphatic_system | 0.55137928 |
| 141 | MP0002168_other_aberrant_phenotype | 0.53089076 |
| 142 | MP0000462_abnormal_digestive_system | 0.52668279 |
| 143 | MP0001845_abnormal_inflammatory_respons | 0.52267573 |
| 144 | MP0002896_abnormal_bone_mineralization | 0.51853810 |
| 145 | MP0002060_abnormal_skin_morphology | 0.51667014 |
| 146 | MP0000003_abnormal_adipose_tissue | 0.50862393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.34614527 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 6.02285565 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.02285565 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.02285565 |
| 5 | Intrahepatic cholestasis (HP:0001406) | 5.26104505 |
| 6 | Xanthomatosis (HP:0000991) | 4.83187576 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.82216240 |
| 8 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.53838636 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.47745879 |
| 10 | Ketosis (HP:0001946) | 4.36009862 |
| 11 | Abnormality of the intrinsic pathway (HP:0010989) | 4.30879740 |
| 12 | Hypoglycemic coma (HP:0001325) | 4.26845911 |
| 13 | Vertebral compression fractures (HP:0002953) | 4.18107590 |
| 14 | Premature rupture of membranes (HP:0001788) | 4.02977103 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.92513730 |
| 16 | Hypobetalipoproteinemia (HP:0003563) | 3.83864566 |
| 17 | Ketoacidosis (HP:0001993) | 3.81679280 |
| 18 | Complement deficiency (HP:0004431) | 3.75248645 |
| 19 | Fat malabsorption (HP:0002630) | 3.74316088 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.69414556 |
| 21 | Hyperammonemia (HP:0001987) | 3.49020498 |
| 22 | Loss of speech (HP:0002371) | 3.38333462 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.26648004 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.26648004 |
| 25 | Hyperglycinuria (HP:0003108) | 3.25032865 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24626949 |
| 27 | Conjugated hyperbilirubinemia (HP:0002908) | 3.20855339 |
| 28 | Protrusio acetabuli (HP:0003179) | 3.20779121 |
| 29 | Gout (HP:0001997) | 3.20618126 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.18759484 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17435976 |
| 32 | Steatorrhea (HP:0002570) | 3.15313319 |
| 33 | Hypoglycemic seizures (HP:0002173) | 3.15138357 |
| 34 | Hyperglycinemia (HP:0002154) | 3.14373178 |
| 35 | Dysostosis multiplex (HP:0000943) | 3.13419120 |
| 36 | Hypolipoproteinemia (HP:0010981) | 3.10636667 |
| 37 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.09451034 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.97667800 |
| 39 | Mucopolysacchariduria (HP:0008155) | 2.97667800 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.95807549 |
| 41 | Increased cerebral lipofuscin (HP:0011813) | 2.94339983 |
| 42 | Abnormality of methionine metabolism (HP:0010901) | 2.93583984 |
| 43 | Prolonged neonatal jaundice (HP:0006579) | 2.93559396 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.92810618 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91178064 |
| 46 | Epidermoid cyst (HP:0200040) | 2.90269113 |
| 47 | Hypoalphalipoproteinemia (HP:0003233) | 2.89354191 |
| 48 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.88475424 |
| 49 | Dicarboxylic aciduria (HP:0003215) | 2.88475424 |
| 50 | Joint hemorrhage (HP:0005261) | 2.86778673 |
| 51 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.85302793 |
| 52 | Abnormality of complement system (HP:0005339) | 2.80204121 |
| 53 | Abnormality of purine metabolism (HP:0004352) | 2.74731050 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.73609134 |
| 55 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.73609134 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.73609134 |
| 57 | Protuberant abdomen (HP:0001538) | 2.73057076 |
| 58 | Axonal loss (HP:0003447) | 2.69968072 |
| 59 | Nuclear cataract (HP:0100018) | 2.69623375 |
| 60 | Glomerulonephritis (HP:0000099) | 2.67541076 |
| 61 | Hyperbilirubinemia (HP:0002904) | 2.66632462 |
| 62 | Vacuolated lymphocytes (HP:0001922) | 2.63707897 |
| 63 | Late onset (HP:0003584) | 2.63315200 |
| 64 | Cervical subluxation (HP:0003308) | 2.56674457 |
| 65 | Joint stiffness (HP:0001387) | 2.54696611 |
| 66 | Vascular calcification (HP:0004934) | 2.53156006 |
| 67 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.48319607 |
| 68 | Pancreatitis (HP:0001733) | 2.43615032 |
| 69 | Lethargy (HP:0001254) | 2.39245096 |
| 70 | Metabolic acidosis (HP:0001942) | 2.38666420 |
| 71 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38504151 |
| 72 | Atrophic scars (HP:0001075) | 2.36377662 |
| 73 | Cardiomegaly (HP:0001640) | 2.33071728 |
| 74 | Cardiovascular calcification (HP:0011915) | 2.31546575 |
| 75 | Symptomatic seizures (HP:0011145) | 2.30191710 |
| 76 | Cerebral edema (HP:0002181) | 2.27479248 |
| 77 | Opisthotonus (HP:0002179) | 2.26612303 |
| 78 | J-shaped sella turcica (HP:0002680) | 2.26339407 |
| 79 | Hypercholesterolemia (HP:0003124) | 2.26197823 |
| 80 | Progressive neurologic deterioration (HP:0002344) | 2.21556316 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.21078910 |
| 82 | Systemic lupus erythematosus (HP:0002725) | 2.20257546 |
| 83 | Interstitial pulmonary disease (HP:0006530) | 2.17897980 |
| 84 | Short nail (HP:0001799) | 2.16144713 |
| 85 | Methylmalonic aciduria (HP:0012120) | 2.15439792 |
| 86 | Skin nodule (HP:0200036) | 2.14153210 |
| 87 | Purpura (HP:0000979) | 2.14130412 |
| 88 | Myocardial infarction (HP:0001658) | 2.12972322 |
| 89 | Irritability (HP:0000737) | 2.12831694 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.10347844 |
| 91 | Mitral stenosis (HP:0001718) | 2.07677556 |
| 92 | Vomiting (HP:0002013) | 2.07616502 |
| 93 | Hepatocellular carcinoma (HP:0001402) | 2.07191983 |
| 94 | Hypokinesia (HP:0002375) | 2.05939749 |
| 95 | Proximal tubulopathy (HP:0000114) | 2.05888672 |
| 96 | Delayed CNS myelination (HP:0002188) | 2.04755861 |
| 97 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.03822483 |
| 98 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.03822483 |
| 99 | Hepatosplenomegaly (HP:0001433) | 2.02224004 |
| 100 | Abdominal distention (HP:0003270) | 2.02167458 |
| 101 | Nonimmune hydrops fetalis (HP:0001790) | 2.01440100 |
| 102 | Brushfield spots (HP:0001088) | 2.01179842 |
| 103 | Distal lower limb muscle weakness (HP:0009053) | 2.00654764 |
| 104 | Abnormality of the Achilles tendon (HP:0005109) | 2.00159045 |
| 105 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.98241343 |
| 106 | Petechiae (HP:0000967) | 1.98126545 |
| 107 | Achilles tendon contracture (HP:0001771) | 1.98048461 |
| 108 | Fragile skin (HP:0001030) | 1.96102504 |
| 109 | Abnormal tarsal ossification (HP:0008369) | 1.95145625 |
| 110 | Abnormal gallbladder morphology (HP:0012437) | 1.93594983 |
| 111 | Ovoid vertebral bodies (HP:0003300) | 1.93459204 |
| 112 | Beaking of vertebral bodies (HP:0004568) | 1.92308737 |
| 113 | Amyloidosis (HP:0011034) | 1.92206449 |
| 114 | Type I transferrin isoform profile (HP:0003642) | 1.92098221 |
| 115 | Osteolytic defects of the hand bones (HP:0009699) | 1.91636381 |
| 116 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91636381 |
| 117 | Retinal atrophy (HP:0001105) | 1.90572681 |
| 118 | Increased serum ferritin (HP:0003281) | 1.89305727 |
| 119 | Hepatic necrosis (HP:0002605) | 1.88430096 |
| 120 | Hyperglycemia (HP:0003074) | 1.88423012 |
| 121 | Elevated alkaline phosphatase (HP:0003155) | 1.88223610 |
| 122 | Hyperuricemia (HP:0002149) | 1.88023423 |
| 123 | Increased purine levels (HP:0004368) | 1.88023423 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.85748449 |
| 125 | Glycosuria (HP:0003076) | 1.85748449 |
| 126 | Rhabdomyolysis (HP:0003201) | 1.83940627 |
| 127 | Nephritis (HP:0000123) | 1.83581421 |
| 128 | Hydroxyprolinuria (HP:0003080) | 1.83411514 |
| 129 | Abnormality of proline metabolism (HP:0010907) | 1.83411514 |
| 130 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83256647 |
| 131 | Sensorimotor neuropathy (HP:0007141) | 1.82945987 |
| 132 | Generalized amyotrophy (HP:0003700) | 1.82762370 |
| 133 | Distal upper limb amyotrophy (HP:0007149) | 1.81542267 |
| 134 | Upper limb amyotrophy (HP:0009129) | 1.81542267 |
| 135 | Abnormal foot bone ossification (HP:0010675) | 1.79992844 |
| 136 | Wormian bones (HP:0002645) | 1.79979587 |
| 137 | Reduced antithrombin III activity (HP:0001976) | 1.79645764 |
| 138 | Asymmetric septal hypertrophy (HP:0001670) | 1.77408845 |
| 139 | Cholecystitis (HP:0001082) | 1.75555753 |
| 140 | Abnormal gallbladder physiology (HP:0012438) | 1.75555753 |
| 141 | Spondylolisthesis (HP:0003302) | 1.74086273 |
| 142 | Ragged-red muscle fibers (HP:0003200) | 1.70915512 |
| 143 | Abnormality of dentin (HP:0010299) | 1.70166427 |
| 144 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70068109 |
| 145 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70068109 |
| 146 | Abnormal protein glycosylation (HP:0012346) | 1.70068109 |
| 147 | Abnormal glycosylation (HP:0012345) | 1.70068109 |
| 148 | Blue sclerae (HP:0000592) | 1.69842887 |
| 149 | Cerebral aneurysm (HP:0004944) | 1.68673000 |
| 150 | Malnutrition (HP:0004395) | 1.67565752 |
| 151 | Elbow flexion contracture (HP:0002987) | 1.64709896 |
| 152 | Neurofibrillary tangles (HP:0002185) | 1.64085339 |
| 153 | Tetraparesis (HP:0002273) | 1.64038886 |
| 154 | Hand muscle atrophy (HP:0009130) | 1.60189341 |
| 155 | Stroke (HP:0001297) | 1.60180702 |
| 156 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.59548311 |
| 157 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.59548311 |
| 158 | Glucose intolerance (HP:0000833) | 1.58524851 |
| 159 | Follicular hyperkeratosis (HP:0007502) | 1.58289231 |
| 160 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.57218900 |
| 161 | Esophageal neoplasm (HP:0100751) | 1.56013568 |
| 162 | Neoplasm of head and neck (HP:0012288) | 1.56013568 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 5.93551046 |
| 2 | BCKDK | 5.84292110 |
| 3 | ERN1 | 4.40188360 |
| 4 | TAOK3 | 3.09403113 |
| 5 | SIK1 | 2.80759393 |
| 6 | INSRR | 2.73434261 |
| 7 | TRIB3 | 2.39980635 |
| 8 | WNK4 | 2.13986824 |
| 9 | ARAF | 2.06773293 |
| 10 | FGFR4 | 2.05528559 |
| 11 | PDK3 | 2.03732877 |
| 12 | PDK4 | 2.03732877 |
| 13 | STK39 | 1.99623828 |
| 14 | FRK | 1.92833361 |
| 15 | EPHB1 | 1.92833215 |
| 16 | PASK | 1.92153054 |
| 17 | PIK3CG | 1.88293731 |
| 18 | TESK1 | 1.79246953 |
| 19 | MAP3K2 | 1.76603766 |
| 20 | SCYL2 | 1.73450880 |
| 21 | IRAK1 | 1.72260416 |
| 22 | PDK2 | 1.66859296 |
| 23 | FLT3 | 1.61670021 |
| 24 | NME2 | 1.55534454 |
| 25 | STK16 | 1.45859663 |
| 26 | MAP2K2 | 1.38421189 |
| 27 | DDR2 | 1.36971166 |
| 28 | PKN2 | 1.31759861 |
| 29 | PAK4 | 1.31645246 |
| 30 | MAP3K3 | 1.25224800 |
| 31 | EPHA3 | 1.24375591 |
| 32 | MAP3K14 | 1.22819215 |
| 33 | TRPM7 | 1.19528019 |
| 34 | PTK6 | 1.18005302 |
| 35 | MST1R | 1.16494182 |
| 36 | TLK1 | 1.16456925 |
| 37 | DAPK3 | 1.14605858 |
| 38 | TAOK2 | 1.11439771 |
| 39 | MAPKAPK3 | 1.09492116 |
| 40 | MOS | 1.07106765 |
| 41 | MAPKAPK5 | 1.05789886 |
| 42 | PRKD2 | 1.04074985 |
| 43 | VRK2 | 1.02997753 |
| 44 | IKBKB | 1.02799265 |
| 45 | TTN | 1.02430231 |
| 46 | MST4 | 0.97462194 |
| 47 | TYK2 | 0.97343673 |
| 48 | GRK7 | 0.95437529 |
| 49 | EEF2K | 0.93436274 |
| 50 | CDC42BPA | 0.92610133 |
| 51 | EPHB2 | 0.91414283 |
| 52 | PHKG1 | 0.90683869 |
| 53 | PHKG2 | 0.90683869 |
| 54 | TBK1 | 0.86456210 |
| 55 | HIPK2 | 0.83424040 |
| 56 | ILK | 0.82881718 |
| 57 | MET | 0.82873241 |
| 58 | EIF2AK3 | 0.81968896 |
| 59 | MYLK | 0.81593198 |
| 60 | MUSK | 0.81590319 |
| 61 | SMG1 | 0.80448669 |
| 62 | LRRK2 | 0.78099713 |
| 63 | BTK | 0.76077969 |
| 64 | JAK2 | 0.75563666 |
| 65 | OXSR1 | 0.74728175 |
| 66 | IRAK3 | 0.74587721 |
| 67 | MAP4K1 | 0.72888437 |
| 68 | ERBB4 | 0.72095048 |
| 69 | BLK | 0.70483810 |
| 70 | TGFBR2 | 0.67171726 |
| 71 | KDR | 0.66589156 |
| 72 | LMTK2 | 0.66045382 |
| 73 | MAP3K1 | 0.65825549 |
| 74 | ABL2 | 0.65679320 |
| 75 | WNK3 | 0.64679612 |
| 76 | JAK1 | 0.63463219 |
| 77 | PDPK1 | 0.62437097 |
| 78 | CSK | 0.61467543 |
| 79 | MAP2K3 | 0.60786568 |
| 80 | TAOK1 | 0.60443912 |
| 81 | ZAP70 | 0.60082806 |
| 82 | EPHA2 | 0.59413553 |
| 83 | PRKD3 | 0.59342629 |
| 84 | KIT | 0.56806762 |
| 85 | TESK2 | 0.56679487 |
| 86 | DYRK1B | 0.56623468 |
| 87 | RPS6KB2 | 0.54022892 |
| 88 | NLK | 0.52915925 |
| 89 | MAPK11 | 0.52004589 |
| 90 | PINK1 | 0.51627354 |
| 91 | CSF1R | 0.51579360 |
| 92 | PDK1 | 0.49539665 |
| 93 | MAP3K12 | 0.49399691 |
| 94 | LIMK1 | 0.45540560 |
| 95 | RPS6KA2 | 0.45124023 |
| 96 | NEK9 | 0.45117747 |
| 97 | JAK3 | 0.44955749 |
| 98 | MAP3K13 | 0.44683427 |
| 99 | CHUK | 0.44369515 |
| 100 | TEC | 0.43898172 |
| 101 | PTK2 | 0.42505501 |
| 102 | MAP3K11 | 0.42461174 |
| 103 | PRKAA2 | 0.42312688 |
| 104 | GSK3A | 0.42263492 |
| 105 | CAMK2G | 0.41825110 |
| 106 | PAK2 | 0.39914427 |
| 107 | STK38 | 0.37995698 |
| 108 | ITK | 0.37507944 |
| 109 | MAP3K5 | 0.37031583 |
| 110 | MAP2K1 | 0.36199082 |
| 111 | RET | 0.35443756 |
| 112 | AKT3 | 0.35369752 |
| 113 | PRKCI | 0.35080103 |
| 114 | CAMKK2 | 0.34645687 |
| 115 | ICK | 0.33985864 |
| 116 | MAPKAPK2 | 0.33621629 |
| 117 | PAK1 | 0.32762675 |
| 118 | MAP3K6 | 0.32744139 |
| 119 | AKT2 | 0.32183352 |
| 120 | IGF1R | 0.32135462 |
| 121 | PRKG2 | 0.30022036 |
| 122 | PIM2 | 0.28153521 |
| 123 | FER | 0.26458545 |
| 124 | PDGFRB | 0.26326454 |
| 125 | TIE1 | 0.26143664 |
| 126 | RIPK1 | 0.25243108 |
| 127 | IKBKE | 0.25043979 |
| 128 | PRKCQ | 0.24882073 |
| 129 | PRKACG | 0.24687495 |
| 130 | PDGFRA | 0.21730506 |
| 131 | RPS6KB1 | 0.21651335 |
| 132 | PRKAA1 | 0.20479882 |
| 133 | MTOR | 0.19977634 |
| 134 | TGFBR1 | 0.17943455 |
| 135 | MAP2K6 | 0.17913399 |
| 136 | PRKD1 | 0.17569205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22453676 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.89870992 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.72504799 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.71440054 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.46352941 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44546682 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44133330 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41621181 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38894006 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.30043105 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27593813 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.26683575 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.19604105 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.19092516 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17664292 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97980805 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 1.97758612 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.97663237 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92881100 |
| 20 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.90163078 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.88080954 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.83919474 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.81877970 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.75757508 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.75702914 |
| 26 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75235831 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67194306 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66911840 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.66508489 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65958498 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65703803 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64038723 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.52093341 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47124476 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46341238 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.46227261 |
| 37 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.43703827 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.43569238 |
| 39 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.39117066 |
| 40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.36558563 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34035621 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31788352 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31370963 |
| 44 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.27893804 |
| 45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22607071 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20088937 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.20045903 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16672392 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15778506 |
| 50 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13807522 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13214055 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.13120712 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.12462775 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.11361225 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.10680783 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05332153 |
| 57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05058477 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 1.02781559 |
| 59 | Bile secretion_Homo sapiens_hsa04976 | 1.02269788 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.01143308 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00299106 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98034085 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97493115 |
| 64 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.95593101 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95520669 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93646301 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92463100 |
| 68 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87945129 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.87571775 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86036760 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84500803 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82561933 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82266503 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.82022843 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.81459798 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81264260 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.75517129 |
| 78 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75029922 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.74665164 |
| 80 | Metabolic pathways_Homo sapiens_hsa01100 | 0.68724536 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64270365 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.63430239 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.62331243 |
| 84 | Asthma_Homo sapiens_hsa05310 | 0.61825319 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61555003 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59145670 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.59117234 |
| 88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.55816829 |
| 89 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54812515 |
| 90 | Leishmaniasis_Homo sapiens_hsa05140 | 0.54463104 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.53905029 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.53767331 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.53578040 |
| 94 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52407275 |
| 95 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.51863036 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50290886 |
| 97 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.49570969 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48453139 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.48438892 |
| 100 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47050288 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.46625272 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46048372 |
| 103 | Legionellosis_Homo sapiens_hsa05134 | 0.43734059 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.43579290 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42442040 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.42333664 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41830744 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39953347 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.39547912 |
| 110 | Hepatitis C_Homo sapiens_hsa05160 | 0.38674603 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37821952 |
| 112 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.36610160 |
| 113 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35202886 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34110173 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33369997 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.32304458 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.31519441 |
| 118 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30307141 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30283971 |
| 120 | Lysine degradation_Homo sapiens_hsa00310 | 0.30069518 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.28362115 |
| 122 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24311264 |
| 123 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18748813 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.18315483 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18075649 |
| 126 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.17820675 |
| 127 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17814042 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.16266835 |
| 129 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.09656282 |
| 130 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.08168311 |

